In this report, the United States Intramuscular Drug Delivery Equipment market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Intramuscular Drug Delivery Equipment in these regions, from 2019 to 2025 (forecast). United States Intramuscular Drug Delivery Equipment market competition by top manufacturers/players, with Intramuscular Drug Delivery Equipment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Antares Pharma Eli Lily Galaxo HMD pharmaceuticals Inovio Pharmaceuticals Merck Novartis Pacira Pharmaceuticals Pfizer Pharmajet Teva Pharmaceutical On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Molecular Structures Polymers Gels Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Infectious Disease Oncology Autoimmune Diseases If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents United States Intramuscular Drug Delivery Equipment Market Report 2019 1 Intramuscular Drug Delivery Equipment Overview 1.1 Product Overview and Scope of Intramuscular Drug Delivery Equipment 1.2 Classification of Intramuscular Drug Delivery Equipment by Product Category 1.2.1 United States Intramuscular Drug Delivery Equipment Market Size (Sales Volume) Comparison by Type ( 2014-2024) 1.2.2 United States Intramuscular Drug Delivery Equipment Market Size (Sales Volume) Market Share by Type (Product Category) in 2018 1.2.3 Molecular Structures 1.2.4 Polymers 1.2.5 Gels 1.2.6 Others 1.3 United States Intramuscular Drug Delivery Equipment Market by Application/End Users 1.3.1 United States Intramuscular Drug Delivery Equipment Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024) 1.3.2 Infectious Disease 1.3.3 Oncology 1.3.4 Autoimmune Diseases 1.4 United States Intramuscular Drug Delivery Equipment Market by Region 1.4.1 United States Intramuscular Drug Delivery Equipment Market Size (Value) Comparison by Region ( 2014-2024) 1.4.2 The West Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.4.3 Southwest Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.4.4 The Middle Atlantic Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.4.5 New England Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.4.6 The South Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.4.7 The Midwest Intramuscular Drug Delivery Equipment Status and Prospect ( 2014-2024) 1.5 United States Market Size (Value and Volume) of Intramuscular Drug Delivery Equipment ( 2014-2024) 1.5.1 United States Intramuscular Drug Delivery Equipment Sales and Growth Rate ( 2014-2024) 1.5.2 United States Intramuscular Drug Delivery Equipment Revenue and Growth Rate ( 2014-2024) 2 United States Intramuscular Drug Delivery Equipment Market Competition by Players/Suppliers 2.1 United States Intramuscular Drug Delivery Equipment Sales and Market Share of Key Players/Suppliers ( 2014-2019) 2.2 United States Intramuscular Drug Delivery Equipment Revenue and Share by Players/Suppliers ( 2014-2019) 2.3 United States Intramuscular Drug Delivery Equipment Average Price by Players/Suppliers ( 2014-2019) 2.4 United States Intramuscular Drug Delivery Equipment Market Competitive Situation and Trends 2.4.1 United States Intramuscular Drug Delivery Equipment Market Concentration Rate 2.4.2 United States Intramuscular Drug Delivery Equipment Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Intramuscular Drug Delivery Equipment Manufacturing Base Distribution, Sales Area, Product Type 3 United States Intramuscular Drug Delivery Equipment Sales (Volume) and Revenue (Value) by Region ( 2014-2019) 3.1 United States Intramuscular Drug Delivery Equipment Sales and Market Share by Region ( 2014-2019) 3.2 United States Intramuscular Drug Delivery Equipment Revenue and Market Share by Region ( 2014-2019) 3.3 United States Intramuscular Drug Delivery Equipment Price by Region ( 2014-2019) 4 United States Intramuscular Drug Delivery Equipment Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019) 4.1 United States Intramuscular Drug Delivery Equipment Sales and Market Share by Type (Product Category) ( 2014-2019) 4.2 United States Intramuscular Drug Delivery Equipment Revenue and Market Share by Type ( 2014-2019) 4.3 United States Intramuscular Drug Delivery Equipment Price by Type ( 2014-2019) 4.4 United States Intramuscular Drug Delivery Equipment Sales Growth Rate by Type ( 2014-2019) 5 United States Intramuscular Drug Delivery Equipment Sales (Volume) by Application ( 2014-2019) 5.1 United States Intramuscular Drug Delivery Equipment Sales and Market Share by Application ( 2014-2019) 5.2 United States Intramuscular Drug Delivery Equipment Sales Growth Rate by Application ( 2014-2019) 5.3 Market Drivers and Opportunities 6 United States Intramuscular Drug Delivery Equipment Players/Suppliers Profiles and Sales Data 6.1 Antares Pharma 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Antares Pharma Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.1.4 Main Business/Business Overview 6.2 Eli Lily 6.2.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Eli Lily Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.2.4 Main Business/Business Overview 6.3 Galaxo 6.3.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Galaxo Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.3.4 Main Business/Business Overview 6.4 HMD pharmaceuticals 6.4.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.4.4 Main Business/Business Overview 6.5 Inovio Pharmaceuticals 6.5.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.5.4 Main Business/Business Overview 6.6 Merck 6.6.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Merck Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.6.4 Main Business/Business Overview 6.7 Novartis 6.7.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Novartis Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.7.4 Main Business/Business Overview 6.8 Pacira Pharmaceuticals 6.8.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.8.4 Main Business/Business Overview 6.9 Pfizer 6.9.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Pfizer Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.9.4 Main Business/Business Overview 6.10 Pharmajet 6.10.2 Intramuscular Drug Delivery Equipment Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Pharmajet Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin ( 2014-2019) 6.10.4 Main Business/Business Overview 6.11 Teva Pharmaceutical 7 Intramuscular Drug Delivery Equipment Manufacturing Cost Analysis 7.1 Intramuscular Drug Delivery Equipment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Intramuscular Drug Delivery Equipment 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Intramuscular Drug Delivery Equipment Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Intramuscular Drug Delivery Equipment Major Manufacturers in 2018 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Intramuscular Drug Delivery Equipment Market Size (Value and Volume) Forecast ( 2019-2025) 11.1 United States Intramuscular Drug Delivery Equipment Sales Volume, Revenue Forecast ( 2019-2025) 11.2 United States Intramuscular Drug Delivery Equipment Sales Volume Forecast by Type ( 2019-2025) 11.3 United States Intramuscular Drug Delivery Equipment Sales Volume Forecast by Application ( 2019-2025) 11.4 United States Intramuscular Drug Delivery Equipment Sales Volume Forecast by Region ( 2019-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer